412 related articles for article (PubMed ID: 26972649)
1. Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
van den Bosch S; Dijkema T; Verhoef LC; Zwijnenburg EM; Janssens GO; Kaanders JH
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):766-74. PubMed ID: 26972649
[TBL] [Abstract][Full Text] [Related]
2. Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer.
Chen AM; Farwell DG; Luu Q; Chen LM; Vijayakumar S; Purdy JA
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1423-9. PubMed ID: 20656416
[TBL] [Abstract][Full Text] [Related]
3. Value of intensity-modulated radiotherapy in Stage IV head-and-neck squamous cell carcinoma.
Dirix P; Nuyts S
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1373-80. PubMed ID: 20362402
[TBL] [Abstract][Full Text] [Related]
4. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
[TBL] [Abstract][Full Text] [Related]
5. Prospective Phase 2 Study of Radiation Therapy Dose and Volume De-escalation for Elective Neck Treatment of Oropharyngeal and Laryngeal Cancer.
Sher DJ; Pham NL; Shah JL; Sen N; Williams KA; Subramaniam RM; Moore W; Chorley R; Ahn C; Khan SM
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):932-940. PubMed ID: 33127491
[TBL] [Abstract][Full Text] [Related]
6. Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.
van den Bosch S; Dijkema T; Kunze-Busch MC; Terhaard CH; Raaijmakers CP; Doornaert PA; Hoebers FJ; Vergeer MR; Kreike B; Wijers OB; Oyen WJ; Kaanders JH
BMC Cancer; 2017 Mar; 17(1):208. PubMed ID: 28327089
[TBL] [Abstract][Full Text] [Related]
7. Recurrence patterns after a decreased dose of 40Gy to the elective treated neck in head and neck cancer.
Nevens D; Duprez F; Daisne JF; Schatteman J; Van der Vorst A; De Neve W; Nuyts S
Radiother Oncol; 2017 Jun; 123(3):419-423. PubMed ID: 28342647
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
9. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for local-regional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB).
Shikama N; Sasaki S; Nishikawa A; Koiwai K; Yoshino F; Hirase Y; Kawakami R; Kadoya M; Oguchi M
Radiology; 2003 Sep; 228(3):789-94. PubMed ID: 12954897
[TBL] [Abstract][Full Text] [Related]
11. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of postoperative simultaneous modulated accelerated radiotherapy for head-and-neck squamous cell carcinoma.
Moon SH; Jung YS; Ryu JS; Choi SW; Park JY; Yun T; Lee SH; Cho KH
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):140-9. PubMed ID: 20732767
[TBL] [Abstract][Full Text] [Related]
13. Radical radiotherapy for squamous cell carcinoma of the larynx, oropharynx and hypopharynx: patterns of recurrence, treatment and survival.
Jones AS; Husband D; Rowley H
Clin Otolaryngol Allied Sci; 1998 Dec; 23(6):496-511. PubMed ID: 9884802
[TBL] [Abstract][Full Text] [Related]
14. Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status.
Huang SH; O'Sullivan B; Xu W; Zhao H; Chen DD; Ringash J; Hope A; Razak A; Gilbert R; Irish J; Kim J; Dawson LA; Bayley A; Cho BC; Goldstein D; Gullane P; Yu E; Perez-Ordonez B; Weinreb I; Waldron J
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1078-85. PubMed ID: 24210079
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of the tumor volume reduction rate in head-and-neck cancer during definitive intensity-modulated radiotherapy for organ preservation.
Yang SN; Liao CY; Chen SW; Liang JA; Tsai MH; Hua CH; Lin FJ
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1096-103. PubMed ID: 20605362
[TBL] [Abstract][Full Text] [Related]
16. Real-life efficacy of volumetric modulated arc therapy in head and neck squamous cell carcinoma.
Moncharmont C; Vallard A; Guy JB; Prades JM; Rancoule C; Magné N
Eur Ann Otorhinolaryngol Head Neck Dis; 2017 May; 134(3):165-169. PubMed ID: 28034705
[TBL] [Abstract][Full Text] [Related]
17. Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.
Spencer CR; Gay HA; Haughey BH; Nussenbaum B; Adkins DR; Wildes TM; DeWees TA; Lewis JS; Thorstad WL
Cancer; 2014 Dec; 120(24):3994-4002. PubMed ID: 25143048
[TBL] [Abstract][Full Text] [Related]
18. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
19. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
20. Radiation dose to the brachial plexus in head-and-neck intensity-modulated radiation therapy and its relationship to tumor and nodal stage.
Truong MT; Romesser PB; Qureshi MM; Kovalchuk N; Orlina L; Willins J
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):158-64. PubMed ID: 22300574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]